| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7390193 | Value in Health Regional Issues | 2015 | 7 Pages |
Abstract
Ondansetron is a dominant intervention that reduces hospitalization rates and costs for health system and caregivers. We recommend assessing the inclusion of this drug in the Colombian Health Benefit Plan for the treatment of gastroenteritis in children under 5 years.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Sara BEcon, MSc, Iván D. MD, MSc, Mateo BEcon, Claudia MD, MSc, Luis E. BEcon, Aurelio BEcon, MSc,